ProfileGDS4177 / 205161_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 64% 64% 40% 47% 64% 59% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated67.3564
GSM603099KU-812 non-treated67.7764
GSM603098KCL-22 Imatinib-treated21.1640
GSM603097KCL-22 non-treated27.4847
GSM603102JURL-MK1 Imatinib-treated67.1264
GSM603101JURL-MK1 non-treated49.9259